Actively Recruiting
IRIS- DESyne X2 in the IRIS-DES Registry
Led by Seung-Jung Park · Updated on 2026-01-02
1000
Participants Needed
6
Research Sites
630 weeks
Total Duration
On this page
Sponsors
S
Seung-Jung Park
Lead Sponsor
C
CardioVascular Research Foundation, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
CONDITIONS
Official Title
IRIS- DESyne X2 in the IRIS-DES Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 19 and more
- Intervention with DeSyne X2 drug-eluting coronary stent
- Agreed with written informed consent form
You will not qualify if you...
- Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
- Life expectancy of 1year and under
- Cardiac shock
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Hallym Hospital
Incheon, South Korea
Actively Recruiting
2
Asan Medical Hospital
Seoul, South Korea
Actively Recruiting
3
Korea University Guro Hospital
Seoul, South Korea
Actively Recruiting
4
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
Withdrawn
5
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Seoul, South Korea
Terminated
6
St.carollo Hospital
Suncheon, South Korea
Terminated
Research Team
J
Jung-hee Ham, RN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here